login

Sensitivity of fibroblasts derived from ataxia-telangiectasia patients to calicheamicin γ1I

Mutation Research LettersPublished 1 November 1990
Neil F. Sullivan, Linden Lyne
Citations23

TL;DR

Treatment with calicheamicin gamma 1I reveals SV40-transformed fibroblasts derived from ataxia telangiectasia (AT) patients to be 6-fold more sensitive to this drug when compared to controls.

Abstract

We report the hypersensitivity of SV40-transformed fibroblasts derived from ataxia telangiectasia (AT) patients to calicheamicin gamma 1I. In common with other free-radical generating agents such as bleomycin and ionizing radiation, treatment with calicheamicin gamma 1I reveals AT derived lines to be 6-fold more sensitive to this drug when compared to controls. Furthermore, in common with ionizing radiation, AT cells did not show dose-dependent inhibition of DNA synthesis after treatment with calicheamicin gamma 1I.

Keywords

Biochemistry, Genetics and Molecular Biology